Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 196 AL 210

Aging phenotype in AD brain organoids: Track to success and challenges

Hossain MK, Kim HR, Chae HJ.

Ageing Res Rev. 2024 Apr;96:102256. doi: 10.1016/j.arr.2024.102256. Epub 2024 Mar 7.

Novel histone post-translational modifications in Alzheimer's disease: current advances and implications

Qin Y, Yang P, He W, Li D, Zeng L, Li J, Zhou T, Peng J, Cao L, Huang W.

Clin Epigenetics. 2024 Mar 9;16(1):39. doi: 10.1186/s13148-024-01650-w.

Pro-Oxidants and Antioxidants Imbalance in Alzheimer's Disease

Mandal PK.

J Alzheimers Dis. 2024;99(s1):S1-S4. doi: 10.3233/JAD-240217.

Involvement of mitochondria in Alzheimer's disease pathogenesis and their potential as targets for phytotherapeutics

Maruthiyodan S, Mumbrekar KD, Guruprasad KP.

Mitochondrion. 2024 May;76:101868. doi: 10.1016/j.mito.2024.101868. Epub 2024 Mar 9.

Updates on mouse models of Alzheimer's disease

Zhong MZ, Peng T, Duarte ML, Wang M, Cai D.

Mol Neurodegener. 2024 Mar 11;19(1):23. doi: 10.1186/s13024-024-00712-0.

Resveratrol: Protective Agent Against Alzheimer's Disease

Subhan I, Siddique YH.

Cent Nerv Syst Agents Med Chem. 2024;24(3):249-263. doi: 10.2174/0118715249287167240222081517.

Drug Design for Alzheimer's Disease: Biologics vs. Small Molecules

Weaver DF.

Curr Alzheimer Res. 2024;20(12):821-826. doi: 10.2174/0115672050301583240307114452.

A span-based model for extracting overlapping PICO entities from randomized controlled trial publications

Zhang G, Zhou Y, Hu Y, Xu H, Weng C, Peng Y.

J Am Med Inform Assoc. 2024 Apr 19;31(5):1163-1171. doi: 10.1093/jamia/ocae065.

Redox imbalance and metabolic defects in the context of Alzheimer disease

Di Domenico F, Lanzillotta C, Perluigi M.

FEBS Lett. 2024 Sep;598(17):2047-2066. doi: 10.1002/1873-3468.14840. Epub 2024 Mar 12.

Oxidative Stress, Endoplasmic Reticulum Stress and Apoptosis in the Pathology of Alzheimer's Disease

Ekundayo BE, Obafemi TO, Adewale OB, Obafemi BA, Oyinloye BE, Ekundayo SK.

Cell Biochem Biophys. 2024 Jun;82(2):457-477. doi: 10.1007/s12013-024-01248-2. Epub 2024 Mar 12.

The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention

Tolar M, Hey JA, Power A, Abushakra S.

Int J Mol Sci. 2024 Feb 27;25(5):2727. doi: 10.3390/ijms25052727.

Age-Related Pathology in Corticobasal Degeneration

Mimuro M, Iwasaki Y.

Int J Mol Sci. 2024 Feb 27;25(5):2740. doi: 10.3390/ijms25052740.

Insights on the Use of Transgenic Mice Models in Alzheimer's Disease Research

Pádua MS, Guil-Guerrero JL, Prates JAM, Lopes PA.

Int J Mol Sci. 2024 Feb 28;25(5):2805. doi: 10.3390/ijms25052805.

Molecular Mechanisms Linking Osteoarthritis and Alzheimer's Disease: Shared Pathways, Mechanisms and Breakthrough Prospects

Umoh IO, Dos Reis HJ, de Oliveira ACP.

Int J Mol Sci. 2024 Mar 6;25(5):3044. doi: 10.3390/ijms25053044.

Firing Alterations of Neurons in Alzheimer's Disease: Are They Merely a Consequence of Pathogenesis or a Pivotal Component of Disease Progression?

Tzavellas NP, Tsamis KI, Katsenos AP, Davri AS, Simos YV, Nikas IP, Bellos S, Lekkas P, Kanellos FS, Konitsiotis S, Labrakakis C, Vezyraki P, Peschos D.

Cells. 2024 Feb 29;13(5):434. doi: 10.3390/cells13050434.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias